SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login
  • This new drug could change how we treat one of the deadliest cancers

    This new drug could change how we treat one of the deadliest cancers

    New clinical trial results underscore the growing promise of KRAS-targeted therapies. Researchers found that a daily oral treatment significantly improved survival for patients with advanced pancreatic cancer, offering hope for better outcomes in a disease with few effective treatment options.

    LEARN MORE

    SEE ALL NEWS
    Recent Posts
    American Cancer Society Updates Prostate Cancer Screening Guideline Prostate Cancer: Advancements in Screening Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk Newly Identified Inhibitors May Boost Chemotherapy Drug’s Ability to Fight Treatment-Resistant Cancers Virtual Tumor Predict Response to Liver Cancer Immunotherapy Ovarian Cancer Researcher Wins Prestigious Lotus Award Blocking Energy Metabolism May Help Treat Aggressive Pediatric Brain Tumor Inherited Long Telomeres May Drive Broad Risk for Lymphoid Cancers How a Division I athlete who never smoked turned his stage 4 ALK+ lung cancer diagnosis into a fight for a cure
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top